SCHEMBL18360392

SCHEMBL18360392

C[C@H](OC(=O)CNC(=O)OC(C)(C)C)C(=O)OCCNC(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GAA P10253 1/20 0.44
IDO1 P14902 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
CA1 P00915 5/20 0.43
CA2 P00918 5/20 0.43
CA12 O43570 4/20 0.43
CA9 Q16790 4/20 0.43
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
MALT1 Q9UDY8 1/20 0.38
EPHX1 P07099 1/20 0.37
CA7 P43166 1/20 0.36
CYP2D6 P10635 1/20 0.35
CTSK P43235 2/20 0.35
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
CTSS P25774 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18354229 0.90 MEN1 (0.43) MEN1KMT2AGAAIDO1TDP1
SCHEMBL18360387 0.86 CTSK (0.45) MEN1KMT2AGAATDP1CA1
SCHEMBL14667662 0.85 MEN1 (0.44) MEN1KMT2AGAAIDO1TDP1
SCHEMBL18687105 0.85 CYP1A2 (0.48) MEN1KMT2AGAATDP1CA1
SCHEMBL22971405 0.85 CYP1A2 (0.48) MEN1KMT2AGAATDP1CA1
SCHEMBL21168987 0.83 CA2 (0.39) MEN1KMT2AGAATDP1CA1
SCHEMBL18668826 0.83 MEN1 (0.40) MEN1KMT2AGAAIDO1TDP1
SCHEMBL18686246 0.83 MEN1 (0.41) MEN1KMT2AGAATDP1CA1
SCHEMBL2152898 0.82 TDP1 (0.51) MEN1KMT2AGAAIDO1TDP1
SCHEMBL28542473 0.82 CA12 (0.41) MEN1KMT2AGAATDP1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3101064-B1 DIAMINE CROSSLINKING AGENT, ACIDIC POLYSACCHARIDE CROSSLINKED BODY, AND MEDICAL MATERIAL SEIKAGAKU KOGYO CO LTD (JP) 2020-07-15 EP disclosed
US-10294195-B2 Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials SEIKAGAKU CORPORATION (JP) 2019-05-21 US disclosed
US-20170001948-A1 DIAMINE CROSSLINKING AGENTS, CROSSLINKED ACIDIC POLYSACCHARIDES AND MEDICAL MATERIALS SEIKAGAKU CORPORATION (JP) 2017-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10294195-B2 Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials SAT1, ACMSD, ADM2 MEN1 2165/4885KMT2A 847/4885GAA 1403/4885
US-20170001948-A1 DIAMINE CROSSLINKING AGENTS, CROSSLINKED ACIDIC POLYSACCHARIDES AND MEDICAL MATERIALS SAT1, ACMSD, ADM2 MEN1 2165/4885KMT2A 847/4885GAA 1403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.